Answer
Syringe labelling is strongly recommended for the Tillomed Laboratories Ltd tranexamic acid 100 mg/ml solution for injection product to reduce fatal medication errors from incorrect administration routes, because it must be given only by slow intravenous injection, never intrathecally or epidurally.
Sources for this answer
- Tranexamic Acid 100 mg/ml Solution for InjectionTillomed Laboratories Ltd · emc · SmPC §4.2 Posology and method of administration · Version 5Document updated
Sources checked